{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-005002","form_type":"8-K","ticker":"BCAX","cik":"0002023658","company_name":"Bicara Therapeutics Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.814675+00:00","generated_at":"2026-05-28T04:04:30.933627+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Bicara Therapeutics furnishes corporate presentation, no new material disclosures","bullets":["Presentation is a general corporate overview; no financial results or guidance provided.","Presentation to be used in investor meetings starting January 13, 2025.","Presentation available on company's IR website at ir.bicara.com."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-005002","json":"https://secwatch.observer/filing/0001193125-25-005002.json","markdown":"https://secwatch.observer/filing/0001193125-25-005002.md","text":"https://secwatch.observer/filing/0001193125-25-005002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023658/000119312525005002/0001193125-25-005002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023658/000119312525005002/d904889d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:04:30.933627+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}